# Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes

> **NCT00471549** · PHASE4 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 18 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Statin (simvastatin)

## Key facts

- **NCT ID:** NCT00471549
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-06
- **Primary completion:** —
- **Final completion:** 1993-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2007-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471549, "Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes". Retrieved via MORVS 2026-10-26 from https://api.morvs.ai/clinical/NCT00471549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*